HRL NYSE Week ended 31 Jul 2026

Weekly Investor Report

Hormel Foods Corporation · Consumer Defensive · Packaged Foods

Open interactive chart View report data
Latest close 25.01 USD
-1.2% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 7.5% above the Trend Line and sits at 62.3% of its 52-week range. The latest completed week returned -1.2%, after a 1.2% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is neither clearly cheap nor expensive. Options positioning is bullish with 47/100 conviction, while the latest news-sentiment score is 57/100. Near-term considerations: volume confirmation is below normal; earnings are due in 26d.

Setup score 44 out of 100
Latest Close 25.01 USD 31 Jul 2026
1W Return -1.2% latest completed week
4W Return 1.2% short-term follow-through
12W Return 22.4% quarterly tape
Trend Breadth 5.8% 3 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
What is working
  • The trend backdrop is active with a 3-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 44.85% based on similar historical setup states.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -1.2% Latest completed week; four-week move 1.2%. Indicator stack 14/63 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 44.85% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Bullish 47/100 conviction; expected move 2.7%. News sentiment 57/100 65 relevant articles in the latest sentiment read. Event risk 26d Next report is scheduled for 27 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 7.5% above the Trend Line and sits at 62.3% of its 52-week range. The latest completed week returned -1.2%, after a 1.2% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.5812-week average 0.23

12-week confirmation

Trend active3/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure8/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.58Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 1.2% over four weeks, 22.4% over 12 weeks, and -7.5% over one year. The current trend has remained active for 3 consecutive weeks.

Performance by holding period

1W-1.2%
4W1.2%
12W22.4%
26W3.1%
52W-7.5%
Active trend streak3 weeks
Active weeks in one year3
Trend breadth5.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.79Latest activity-pressure read.
Pressure change-14.1%Four-week change in activity pressure.
Leadership-2.29Latest relative-leadership reading.
RS change59.5%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 30 Apr 2026 Field coverage 100% Model confidence 100%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength8/100Blend of value, momentum, and quality. Underlying universe rank 93; rank 1 is best.
Value27/100Relative valuation strength. Underlying universe rank 74; rank 1 is best.
Quality20/100Profitability and accounting quality. Underlying universe rank 81; rank 1 is best.
Momentum21/100Medium-term price momentum. Underlying universe rank 80; rank 1 is best.
Growth3/100Revenue and earnings growth. Underlying universe rank 98; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework36/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
29.8x
Price divided by trailing earnings.
Price / sales
1.1x
Market value relative to trailing revenue.
EV / EBITDA
15.9x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
8.3%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
15.7%
Gross profit retained from each unit of revenue.
Operating margin
6.0%
Operating profit retained from revenue.
Free-cash-flow margin
10.8%
Free cash flow generated from revenue.
Return on invested capital
5.2%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
2.5%
Latest one-year revenue growth.
EPS growth
-37.5%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
2.6%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
4.6%
Cash dividends relative to market value.
Buyback yield
-0.1%
Net share repurchases relative to market value.
Shareholder yield
4.5%
Dividend yield plus net buyback yield.
Net debt / EBITDA
2.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

HRL shows bullish options pressure with a 47/100 conviction score, put-call volume ratio of 0.38, expected move of 2.7%, and Sharemaestro trend signal active.

Conviction47/100
Expected move2.7%
Put/call volume0.38
Pressure53
Speculation40
Volatility31
Trend agreement50
Open options detail
Insider activity11 / 2

11 acquisitions and 2 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment57/100

Weighted news tone is neutral across 65 relevant articles.

24 positive · 39 neutral · 2 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings26dNext report is scheduled for 27 Aug 2026; event risk rises as the date approaches.
Options expected move2.7%Nearest-chain priced movement where available.
52-week drawdown-11.4%Distance below the 52-week high.
13-week volatility4.9%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+9.7%Week of 26 Jun.
Worst week-7.3%Week of 13 Mar.
Latest week-1.2%Week of 31 Jul.

Shape of recent returns

Strong gains5
Modest gains7
Flat weeks0
Modest losses7
Sharp losses7
Recent vol4.9%13-week weekly-return volatility.
Base vol4.3%52-week weekly-return volatility.
Up/down split25/26Count of positive and negative weeks in the 52-week window.
Average skew3.3% / -3.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape39/100

Trend, activity pressure, participation, and risk combine to a 39/100 tape read.

 Indicator analysis41/100

Latest 12-week confirmation: trend 3/12, activity pressure 8/12, relative leadership 1/12.

Activity pressure 0.58; No reversal markers Next-Week ExpectancyNegative 44.85%

Next-week expectancy is negative with a 44.85% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors17/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 72; Small Cap Core rank 43 SVQF36/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 651.0 of 1013 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Options59/100

HRL shows bullish options pressure with a 47/100 conviction score, put-call volume ratio of 0.38, expected move of 2.7%, and Sharemaestro trend signal active.

Bullish · Call-side pressure · Expected move 2.7% Sentiment57/100

Weighted news tone is neutral across 65 relevant articles.

Hormel Foods Corp. stock underperforms Friday when compared to competitors Insiders11 / 2

11 acquisitions and 2 disposals in the latest 180-day insider tape.

 Earnings26d

Next report is scheduled for 27 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202625.01 USD-1.2%23.27 USD27.55 USD0.79-2.2922.9MOn
24 Jul 202625.31 USD-0.3%23.19 USD27.63 USD0.80-0.6213.5MOn
17 Jul 202625.39 USD3.9%23.13 USD27.70 USD0.93-1.4719.0MOn
10 Jul 202624.44 USD-1.1%23.06 USD27.77 USD0.90-7.1919.7MOff
3 Jul 202624.70 USD-5.7%23.02 USD27.84 USD0.92-5.6617.8MOff
26 Jun 202626.20 USD9.7%22.99 USD27.91 USD0.841.4426.4MOff
19 Jun 202623.87 USD-2.4%22.87 USD27.97 USD0.69-10.3316.5MOff
12 Jun 202624.46 USD3.5%22.81 USD28.04 USD0.41-8.1419.6MOff
5 Jun 202623.62 USD1.7%22.73 USD28.12 USD-0.06-11.5625.3MOff
29 May 202623.23 USD9.4%22.66 USD28.20 USD-0.39-15.9664.0MOff
22 May 202621.24 USD7.6%22.58 USD28.29 USD-0.72-22.8425.1MOff
15 May 202619.74 USD-3.4%22.65 USD28.37 USD-0.81-28.4223.1MOff
8 May 202620.44 USD-4.2%22.77 USD28.47 USD-0.67-26.5922.5MOff
1 May 202621.33 USD-1.0%22.85 USD28.57 USD-0.61-22.4624.1MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.